CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
cryoICE® system (AtriCure, Inc) with CryoSphere (CryoS) probedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05859061
NCT05859061N/ACompleted

Intraoperative Cryoanalgesia for Pain Management After Sternotomy: A Randomized Pilot Trial

Northwestern University·interventional·Posted May 15, 2023·Updated Jun 18, 2025

In Brief

A clinical study evaluating cryoICE® system (AtriCure, Inc) with CryoSphere (CryoS) probe for Pain, Postoperative. Completed, enrolled 32 participants across 1 site.

Detailed Summary

This study will investigate the feasibility of cryoanalgesia in patients undergoing cardiac surgery via a median sternotomy. Cryoanalgesia is a technique that uses extremely cold temperatures to temporarily ablate nerves and block pain signals. Cryoanalgesia has been used for decades for pain control after thoracic surgery and has been associated with decreased opioid consumption, decreased pain scores, and shorter hospital stays. The results of this study may lead to a useful alternative for pain control in cardiac surgery patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedMay 15, 2023
Enrollment StartApr 10, 2023
Primary CompletionJul 20, 2024
Study CompletionFeb 13, 2025
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 3.1 years ago

Interventions

cryoICE® system (AtriCure, Inc) with CryoSphere (CryoS) probedevice

Per manufacturer instructions, the cryoprobe will be positioned under direct visualization and ablation of the intercostal nerve will be performed 2-4 cm lateral to the internal mammary artery near the mid-clavicular line. The study team plans to perform each cryoablation (-50°C to -70°C) for 120 seconds to sustain an ablation length of 2-3 cm at each intercostal nerve (bilateral T2 - T6). The probe will be removed after defrosting to avoid mechanical damage to the intercostal nerve. Cryoablation will be performed once hemostasis is achieved and prior to sternal wire placement and chest closure by a provider from the cardiac surgery team.